Glyoxalase System as a Therapeutic Target against Diabetic Retinopathy
Hyperglycemia, a defining characteristic of diabetes, combined with oxidative stress, results in the formation of advanced glycation end products (AGEs). AGEs are toxic compounds that have adverse effects on many tissues including the retina and lens. AGEs promote the formation of reactive oxygen sp...
Saved in:
Main Authors: | Gemma Aragonès (Author), Sheldon Rowan (Author), Sarah G Francisco (Author), Wenxin Yang (Author), Jasper Weinberg (Author), Allen Taylor (Author), Eloy Bejarano (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TRPC proteins contribute to development of diabetic retinopathy and regulate glyoxalase 1 activity and methylglyoxal accumulation
by: Robin Sachdeva, et al.
Published: (2018) -
Glyoxalase 2: Towards a Broader View of the Second Player of the Glyoxalase System
by: Andrea Scirè, et al.
Published: (2022) -
Protection of Polyphenols against Glyco-Oxidative Stress: Involvement of Glyoxalase Pathway
by: Laura Cianfruglia, et al.
Published: (2020) -
Mechanism and therapeutic targets of circulating immune cells in diabetic retinopathy
by: Bowen Zhao, et al.
Published: (2024) -
Polymorphisms in Glyoxalase I Gene Are Not Associated with Glyoxalase I Expression in Whole Blood or Markers of Methylglyoxal Stress: The CODAM Study
by: Kim Maasen, et al.
Published: (2021)